Sol Bio operates a biotechnology platform focused on the research and development of in-vitro diagnostic products for immuno-isolation and analysis of exosomes.

Vision and Mission: The company’s vision is to pioneer early diagnosis products for various cancers and chronic diseases using their unique exosome isolation technology and on-site biosensor.

Noteworthy Points:

• Founded in 2019, Sol Bio is at the forefront of developing diagnostic products for early detection of cancers.
• Successfully raised $3.07M in a Series A funding round.
• Holds a promising pipeline for diagnosis products to be launched in major markets, including the U.S..